[ RadSafe ] Cleveland BioLabs Receives First U.S. Patent For Radiation Protection Drug CBLB502

[Cary Renquist]

Since blocking apoptosis seems like a good way to induct cancer, I
assume that this would only be used in cases of extremely high exposure,
i.e. life threatening doses.

Cary
-- 
Cary.renquist at ezag.com


Cleveland BioLabs Receives First U.S. Patent For Radiation Protection
Drug CBLB502 
http://bit.ly/8eaxo4

U.S. Patent and Trademark Office has issued US Patent No. 7,638,485
titled "Modulating Apoptosis" covering the method of protecting a mammal
from radiation using flagellin or its derivatives, including CBLB502.
This patent was already granted by the nine member countries of the
Eurasian Patent Organization (EAPO), and two additional nations.